NEW YORK (GenomeWeb) – Cambridge Isotope Laboratories has announced a deal with IROA Technologies to develop and distribute metabolite quantitation kits for mass spectrometry-based profiling.

Under the terms of the agreement, the partners will work on IROA's Biochemical Quantitation Kits, which chemically label metabolites for isotopic ratio outlier analysis.  In a statement, the firms said the kits can help researchers eliminate technical and analytical variance, thus increasing reliability.

Financial and other terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.